ABSTRACT Background: Serum phosphorus concentrations are associated with an increased risk of cardiovascular disease (CVD) and mortality in patients with renal insufficiency. This association has also been reported in Western individuals without chronic kidney disease (CKD). Objective: It is unclear, however, whether this correlation occurs in Korean individuals without CKD, who usually ingest less phosphorus than do Western individuals. Design: We reviewed the findings in 402 healthy Korean adults with a mean (6SD) age of 50.8 6 8.5 y (n = 257 men and 145 women) and a glomerular filtration rate of 83.5 6 14.1 mL/min, who underwent health screening with electron-beam computed tomography (EBCT). The study population was separated into 4 groups on the basis of the coronary calcium concentration (Agatston score: 0, .0 to 10, .10 to 100, and .100). Mean serum phosphorus concentrations, measured !10 y before EBCT, were compared. Results: Multivariate analysis showed that age (P = 0.001), male sex (P = 0.002), family history of CVD (P = 0.006), serum glucose (P = 0.003), and serum phosphorus .3.6 mg/dL (P = 0.008) were significant factors influencing the coronary calcification group with an Agatston score .100, when those with an Agatston score of 0 were considered as the reference group. Compared with the group with a serum phosphorus concentration 3.3 mg/dL, the OR of an Agatston score .100 in individuals with a serum phosphorus concentration .3.6 to 3.9 mg/dL was 3.89 (95% CI: 1.43, 10.63; P = 0.008) and in those with a serum phosphorus concentration .3.9 mg/dL was 3.17 (95% CI: 1.19, 8.41; P = 0.021). Conclusion: A lower concentration of serum phosphorus within the normal range could be associated with less calcification of the coronary artery in Koreans with normal renal function.
INTRODUCTION
Cardiovascular disease remains the most common cause of mortality in patients with ESRD 4 (1). Patients with ESRD have a rate of coronary artery disease far in excess of the nonuremic population (2) . In addition, renal insufficiency is independently associated with increased CVD-related and all-cause mortality rates (3) , and CVD is strongly associated with coronary artery calcification (4) . The severity of calcification can be measured on the basis of the Agatston score (coronary artery calcium score) by using EBCT (5) (6) (7) .
Hyperphosphatemia and high CaPs are common in patients with CKD or ESRD, which are major risk factors for vascular calcification and CVD (8) . Several observational studies have shown that high serum phosphorus concentrations can cause coronary artery calcification and increase the risk of cardiovascular mortality in CKD patients (9) (10) (11) (12) (13) (14) . Considering the significantly higher cardiovascular mortality in patients with renal insufficiency, it is important to control the concentration of serum phosphorus strictly to reduce the associated mortality.
However, sufficient data are not available to determine whether the relation between high serum phosphorus concentrations and coronary artery disease in patients with renal insufficiency is still valid in the general population with normal renal function. If so, individual serum phosphorus concentrations should be reduced to escape the risk of coronary artery calcification. In the current study, we investigated whether a lower concentration of serum phosphorus within the previously alleged normal range (2.5'4.5 mg/dL) was associated with a lower Agatston score, which would suggest less coronary artery calcification in the subjects with normal renal function.
SUBJECTS AND METHODS

Populations
The study cohort consisted of individuals aged !18 y and who underwent EBCT at the general health promotion center between January 2007 and April 2009 at the Asan Medical Center, a 2800-bed tertiary referral hospital, and whose serum phosphorus concentrations had also been measured 10 y ago during health screening.
Subjects were excluded if they had heart failure (left ventricular ejection fraction ,40%), CKD (eGFR ,60 mL Á min 21 Á 1.73 m
22
, as calculated with the Modification of Diet in Renal Disease equation or a dipstick test showing urine albumin .1+), or experienced overt vascular events at the time of serum phosphorus measurement. Overt vascular events were defined as follows: history of percutaneous coronary intervention or coronary artery bypass grafting for coronary artery disease, peripheral artery disease, and cerebrovascular disease.
Data collection
Data were obtained from the electronic medical recording system of the Asan Medical Center. Coronary artery calcification was quantified as the Agatston score on EBCT. Age, sex, BMI, previous diabetes and hypertension, systolic and diastolic blood pressure, cigarette smoking, alcohol intake, level of education, and family history of CVD were reviewed. Positive alcohol intake was defined as the frequency of alcohol consumption more than twice a week, according to the results of questionnaire survey. Hemoglobin concentrations, urinary albumin (by dipstick test), and serum concentrations of creatinine, calcium, phosphorus, glucose, albumin, total cholesterol, HDL cholesterol, and triglycerides were also recorded. CaP was defined as the product of corrected serum calcium and serum phosphorus concentrations.
Statistical analysis
Epidemiologic and clinical variables of the study population were summarized as means 6 SDs for continuous variables and as percentages for discrete variables. The study population was separated into 4 groups on the basis of their coronary calcium concentration (Agatston score: 0, .0 to 10, .10 to 100, and .100). A baseline-category logit model was applied to identify factors related to coronary artery calcification. The group with an Agatston score of 0 was considered the reference. To construct the multivariate models, those variables identified as significant in the univariate analysis and those considered clinically relevant were introduced in the model, including serum phosphorus concentration, and then backward elimination was performed. To examine the association between the concentration of serum phosphorus and coronary calcification, the subjects were also divided into 4 groups on the basis of their serum phosphorus concentrations: 3.3 mg/dL, .3.3 to 3.6 mg/dL, .3.6 to 3.9 mg/dL, and .3.9 mg/dL. Baseline characteristics were analyzed by chi-square and 1-factor ANOVA. All statistical tests were 2-sided, and P , 0.05 was considered significant.
RESULTS
Of the 529 patients who underwent EBCT during the study period, 84 were excluded because of heart failure, CKD, or prior overt vascular events, and 43 were excluded because their Agatston scores on EBCT were missing. Baseline characteristics of the 402 patients in the study population are summarized in Table 1 . All subjects were ethnically Korean [n = 257 men (64%) and 145 women (36%)], were aged 50.8 6 8.5 y, and had a BMI (in kg/m 2 ) of 24.6 6 2.9. Of these patients, 13% had a previous diagnosis of diabetes, 16% had hypertension, and 19% had a family history of CVD. The mean serum phosphorus concentration was 3.6 6 0.5 mg/dL, corrected total calcium was 8.8 6 0.4 mg/dL, and CaP was 32.1 6 5.1 mg 2 /dL 2 . The mean eGFR was .60.0 mL/min. Male sex, diabetes, hypertension, family history of CVD, older age, and higher BMI, systolic blood pressure, diastolic blood pressure, serum glucose, total: HDL-cholesterol ratio, and triglycerides were associated with the group with a higher Agatston score.
Multivariate models showed that age (P = 0.001), male sex (P = 0.005), family history of CVD (P = 0.009), serum glucose (P = 0.004), and total:HDL-cholesterol ratio (P = 0.023) were risk factors for coronary calcification in the group with an Agatston score .10 and 100, when the group with an Agatston score of 0 was considered as the reference ( Table 2) . Similarly, age (P = 0.001), male sex (P = 0.002), family history of CVD (P = 0.006), serum glucose (P = 0.003), total: HDL-cholesterol ratio (P = 0.001), and serum phosphorus .3.6 mg/dL (adjusted OR: 2.47; 95% CI: 1.27, 4.84; P = 0.008) were risk factors for the group with an Agatston score .100. However, corrected total serum calcium and CaPs were not significant risk factors for any Agatston category.
To investigate the association between baseline serum phosphorus concentration and coronary calcification, we divided subjects into 4 groups on the basis of their serum phosphorus concentrations ( 3.3, .3.3 to 3.6, .3.6 to 3.9, and .3.9 mg/dL). Women (P = 0.001) and nonsmokers (P = 0.031) had significantly higher serum phosphorus concentrations than did men and smokers, respectively ( Table 3 ). Higher serum phosphorus was significantly associated with old age (P = 0.001), higher serum calcium (P = 0.001), lower hemoglobin (P = 0.003), and lower serum creatinine (P = 0.007) but not with eGFR (P = 0.991). Although univariate analysis showed no correlation between serum phosphorus concentrations and coronary calcification, multivariate analysis showed that a serum phosphorus concentration .3.6 to 3.9 mg/dL (OR: 3.89; 95% CI: 1.43, 10.63; P = 0.008) and a serum phosphorus concentration .3.9 mg/dL (OR: 3.17; 95% CI: 1.19, 8.41; P = 0.021) were significant risk factors for an Agatston score .100, compared with a serum phosphorus concentration 3.3 mg/dL ( Table 4) . DISCUSSION Most cases of acute myocardial infarction occur in individuals with high coronary calcium score percentiles (15) . The coronary calcium score is suggested to be a predictor of future coronary events (7). Higher serum phosphorus concentrations, even when within the normal range, may be a risk factor for coronary artery atherosclerosis on the basis of coronary calcium scores obtained by EBCT in healthy young adults (16) . Higher serum phosphorus concentrations were shown to be associated with an increased risk of cardiovascular disease in individuals without CKD and CVD in the community (17) . This study showed that lower concentrations of serum phosphorus within the previously alleged normal range was associated with lower Agatston score, suggesting less coronary artery calcification in the subjects with normal renal function. The results of our study suggest that the association between serum phosphorus concentration and calcium scores has a triangular relation between calcium score, coronary events, and serum phosphorus. Therefore, a new normal range of serum phosphorus without harmful effects on coronary calcification should be determined on the basis of results, including ours, in other studies (16, 17) .
Phosphorus is involved in various biological functions, including energy metabolism, cellular signaling, nucleic acid synthesis, and the stabilization of cell membranes. Serum phosphorus concentrations can be controlled within a narrow range by PTH, 1,25-dihydroxy vitamin D 3 , and fibroblast growth factor-23 (18, 19) . Although phosphorus is an essential element for 1 The study population was separated into 4 groups by coronary calcium concentration (Agatston score: 0, .0 to 10, .10 to 100, and .100). BP, blood pressure; CaP, calcium-phosphorus product; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate.
2 Chi-square and 1-factor ANOVA. (8) .
Several studies reported that higher serum phosphorus and higher CaP concentrations increase the risks of CVD and mortality in patients with ESRD requiring dialysis (9, 10, 13, 14) . Similar results have been observed in patients with early CKD who do not require renal replacement therapy (11, 12) . Furthermore, a post hoc analysis of data from the CARE (Cholesterol And Recurrent Events) study of patients with prior CVD and normal kidney function found that higher serum phosphorus (.4.0 mg/dL compared with ,3.4 mg/dL) increased the risks of acute myocardial infarction and mortality (20) . These associations were also assessed in healthy populations with no CVD or CKD. Individuals with a serum phosphorus concentration .3.5 mg/dL had a higher incidence of cardiovascular events than did those with a serum phosphorus concentration ,2.8 mg/dL (17), 
1 The study population was divided into 4 groups on the basis of serum phosphorus concentrations: 3.3, .3.3 to 3.6, .3.6 to 3.9, and .3.9 mg/dL. BP, blood pressure; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate.
2 Chi-square and 1-factor ANOVA. and those with a serum phosphorus concentration .3.9 mg/dL had a higher level of coronary calcification than did those with a serum phosphorus concentration ,3.3 mg/dL (16) . These findings are consistent with the results of the current study. The risk of coronary calcification was significantly higher in individuals with a serum phosphorus concentration .3.9 mg/dL than in those with a serum phosphorus concentration ,3.3 mg/ dL. It suggested that even a relatively higher concentration of serum phosphorus within the normal range could be a risk factor for cardiovascular disease. The 2007 National Health and Nutrition Report by the Korean Ministry of Health and Welfare found that the mean phosphorus intake by Koreans was 1068.4 6 13.1 mg/d Although we were unable to determine the amount of phosphorus intake in our study population, it was almost certainly lower than the 1766.0 6 1007.0 mg/d reported in a Western population (16) and lower than the phosphorus intakes in men of ;1600 mg/d and in women of ;1200 mg/d in the United States, according to NHANES and the Continuing Survey of Dietary Intakes. Despite the fact that Koreans ingest a relatively low amount of dietary phosphorus, the lower concentration of serum phosphorus was associated with a lower Agatston score in our study. Considering the results of previous studies, a new normal range of serum phosphorus is needed.
Serum phosphorus has been found to affect smooth muscle calcification. Human aortic smooth muscle cells cultured in media containing .2.0 mmol P/L showed dose-dependent increases in mineral deposition (21) . An elevated serum phosphorus concentration inhibits the synthesis of 1,25-dihydroxyvitamin D (22, 23) and stimulates the secretion of PTH (24) . A lower concentration of 1,25-dihydroxyvitamin D has been hypothesized to accelerate coronary calcification (25) and to decrease myocardial contractility (26) . Higher PTH concentrations may also have proinflammatory effects, inducing the production of IL-6 (27, 28) and subsequently an increase in the risk of CVD (29, 30) . Even though the serum concentrations of 1,25-dihydroxyvitamin D and PTH in our study patients were not available, those mechanisms linking higher serum phosphorus concentrations and the development of CVD in subjects with normal kidney function might not be impossible. However, a large-scale prospective epidemiologic study will be necessary to elucidate the exact mechanism that higher serum phosphorus could accelerate the development of CVD in the subjects with normal renal function.
In this study, a higher serum phosphorus concentration correlated with old age, female sex, nonsmoking status, higher serum calcium, and lower hemoglobin. However, female sex and nonsmoking were not the risk factors for CVD. Higher serum calcium and lower hemoglobin concentrations were within normal ranges. These relations may be ascribed to the limitation of this retrospective study.
Our study had several limitations. First, this study was analyzed with a focus on an Agatston score .100 (indicating a high risk of coronary calcification) instead of tertiles of Agatston score in the descriptive statistics of this retrospective study. Second, we had no data on serum concentrations of PTH, 1,25-dihydroxyvitamin D, and inflammatory markers; therefore, we investigated a causal relation between serum phosphorus and coronary calcification. Third, our study subjects may not be representative of the Korean population because of a small number of patients, a higher proportion of males, and older subjects compared with the general Korean population. Relatively wide 95% CIs in this study may have been affected by cohort size. Finally, we could not include information about phosphorus intakes and long-term survival of the study population.
In conclusion, we observed that the lower concentration of serum phosphorus within the normal range was associated with a lower Agatston score, which suggests less coronary artery calcification in Koreans with normal renal function. Prospective studies are needed to assess the effects of serum phosphorus on CVD and long-term survival and to determine whether PTH, vitamin D, and inflammatory markers are involved in the association between serum phosphorus and coronary calcification.
